| Mark Smith | |||||||||||||||||
|
MB, ChB, FRACP, FRCPA Areas of clinical interest include; Haemophilia and inhibitor management Clinical and laboratory responsibility for patient management in general and malignant haematology Genetic diagnosis and pre-implantation genetic diagnosis Anticoagulant strategies including thrombophilia during pregnancy and thrombophilia-related recurrent pregnancy loss General and malignant haematology |
|
||||||||||||||||
|
|||||||||||||||||